Ribbat M - Search Results

1

[Acute therapy of episodic and chronic cluster headache with sumatriptan s.c. Results of a one-year long-term study].

Göbel H, Lindner V, Pfaffenrath V, Ribbat M, Heinze A, Stolze H. Göbel H, et al. Among authors: ribbat m. Nervenarzt. 1998 Apr;69(4):320-9. doi: 10.1007/s001150050277. Nervenarzt. 1998. PMID: 9606683 German.

2

Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study.

Göbel H, Lindner V, Heinze A, Ribbat M, Deuschl G. Göbel H, et al. Among authors: ribbat m. Neurology. 1998 Sep;51(3):908-11. doi: 10.1212/wnl.51.3.908. Neurology. 1998. PMID: 9748059 Clinical Trial.

3

[Prophylaxis and treatment of drug-induced persistent headache. Therapy recommendation of the German Society for Migraine and Headache].

Haag G, Baar H, Grotemeyer KH, Pfaffenrath V, Ribbat MJ, Diener HC. Haag G, et al. Among authors: ribbat mj. Schmerz. 1999 Feb 18;13(1):52-7. doi: 10.1007/s004829900016. Schmerz. 1999. PMID: 12799950 German. No abstract available.

4

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators; Holmans P, Jones L, Tabrizi SJ. Moss DJH, et al. Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20. Lancet Neurol. 2017. PMID: 28642124

5

Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY.

Orth M; European Huntington's Disease Network; Handley OJ, Schwenke C, Dunnett S, Wild EJ, Tabrizi SJ, Landwehrmeyer GB. Orth M, et al. J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1409-12. doi: 10.1136/jnnp.2010.209668. Epub 2010 Nov 19. J Neurol Neurosurg Psychiatry. 2011. PMID: 21097549 No abstract available.

6

β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease.

Vittori A, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ; Registry investigators of the European Huntington's Disease Network. Vittori A, et al. J Huntingtons Dis. 2013;2(1):107-24. doi: 10.3233/JHD-130002. J Huntingtons Dis. 2013. PMID: 25057107

7

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.

McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L; REGISTRY Investigators of the European Huntington's Disease Network. McNulty P, et al. J Huntingtons Dis. 2018;7(3):209-222. doi: 10.3233/JHD-170263. J Huntingtons Dis. 2018. PMID: 30103338

8

Followership styles scrutinized: temporal consistency and relationships with job attitudes and self-efficacy.

Ribbat M, Nohe C, Hüffmeier J. Ribbat M, et al. PeerJ. 2023 Oct 27;11:e16135. doi: 10.7717/peerj.16135. eCollection 2023. PeerJ. 2023. PMID: 37908416 Free PMC article.

9

Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study.

Färkkilä M, Diener HC, Géraud G, Láinez M, Schoenen J, Harner N, Pilgrim A, Reuter U; COL MIG-202 study group. Färkkilä M, et al. Lancet Neurol. 2012 May;11(5):405-13. doi: 10.1016/S1474-4422(12)70047-9. Epub 2012 Mar 28. Lancet Neurol. 2012. PMID: 22459549 Clinical Trial.

10

Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial.

Ferrari MD, Färkkilä M, Reuter U, Pilgrim A, Davis C, Krauss M, Diener HC; European COL-144 Investigators. Ferrari MD, et al. Cephalalgia. 2010 Oct;30(10):1170-8. doi: 10.1177/0333102410375512. Epub 2010 Jun 15. Cephalalgia. 2010. PMID: 20855362 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters